Literature DB >> 26768359

Small-molecule inhibitors of USP7 induce apoptosis through oxidative and endoplasmic reticulum stress in cancer cells.

Gibok Lee1, Taek-In Oh1, Ki Bum Um1, Hyeshin Yoon1, Jaekyoung Son2, Byeong Mo Kim3, Hong-Il Kim1, Hackyoung Kim1, Young Jun Kim1, Chang-Soo Lee1, Ji-Hong Lim4.   

Abstract

USP7 is a deubiquitinating enzyme that involves the ubiquitin proteasome system (UPS) to maintain regulation of protein synthesis and degradation. The well-known substrate of USP7 is the Mdm2-p53 complex. In fact, several studies have reported that functional inhibition of USP7 induces cancer cell apoptosis through activation of p53. However, the contribution of oxidative or endoplasmic reticulum (ER) stress, which is commonly induced by inhibition of the UPS for USP7 inhibitor-mediated apoptosis in cancer cells, has not been investigated. In contrast to previous reports, we show that p53 is not critical during USP7 inhibitor-induced apoptosis in several cancer cells. Inhibition of deubiquitinating enzyme activities by USP7 inhibitors causes ER stress by accumulating polyubiquitinated proteins in cancer cells. Furthermore, we demonstrate that USP7 inhibitors increase intracellular reactive oxygen species and mainly cause cancer cell apoptosis. Taken together, our results reveal that oxidative and ER stress, rather than the Mdm2-p53 axis, mainly contributes to USP7 inhibitor-mediated apoptosis in cancer cells.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; ER stress; ROS; USP7 inhibitor

Mesh:

Substances:

Year:  2016        PMID: 26768359     DOI: 10.1016/j.bbrc.2016.01.021

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  The deubiquitinase USP7 regulates oxidative stress through stabilization of HO-1.

Authors:  Ming Gao; Zijuan Qi; Min Deng; Hongyang Huang; Zhijie Xu; Guijie Guo; Jiajun Jing; Xiaofeng Huang; Ming Xu; Jake A Kloeber; Sijin Liu; Jinzhou Huang; Zhenkun Lou; Jinxiang Han
Journal:  Oncogene       Date:  2022-07-11       Impact factor: 8.756

2.  USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.

Authors:  Gouranga Saha; Sibani Sarkar; Partha S Mohanta; Krishna Kumar; Saikat Chakrabarti; Malini Basu; Mrinal K Ghosh
Journal:  Oncogene       Date:  2022-10-15       Impact factor: 8.756

3.  Molecular basis of USP7 inhibition by selective small-molecule inhibitors.

Authors:  Andrew P Turnbull; Stephanos Ioannidis; Wojciech W Krajewski; Adan Pinto-Fernandez; Claire Heride; Agnes C L Martin; Louise M Tonkin; Elizabeth C Townsend; Shane M Buker; David R Lancia; Justin A Caravella; Angela V Toms; Thomas M Charlton; Johanna Lahdenranta; Erik Wilker; Bruce C Follows; Nicola J Evans; Lucy Stead; Cristina Alli; Vladislav V Zarayskiy; Adam C Talbot; Alexandre J Buckmelter; Minghua Wang; Crystal L McKinnon; Fabienne Saab; Joanna F McGouran; Hannah Century; Malte Gersch; Marc S Pittman; C Gary Marshall; Tony M Raynham; Mary Simcox; Lorna M D Stewart; Sheila B McLoughlin; Jaime A Escobedo; Kenneth W Bair; Christopher J Dinsmore; Tim R Hammonds; Sunkyu Kim; Sylvie Urbé; Michael J Clague; Benedikt M Kessler; David Komander
Journal:  Nature       Date:  2017-10-18       Impact factor: 49.962

Review 4.  Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors.

Authors:  Shiyao Chen; Yunqi Liu; Huchen Zhou
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

5.  Cationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2-3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cells.

Authors:  Vivian Juang; Hsin-Pin Lee; Anya Maan-Yuh Lin; Yu-Li Lo
Journal:  Int J Nanomedicine       Date:  2016-11-15

6.  Active site-targeted covalent irreversible inhibitors of USP7 impair the functions of Foxp3+ T-regulatory cells by promoting ubiquitination of Tip60.

Authors:  Feng Wang; Liqing Wang; Jian Wu; Ivan Sokirniy; Phuong Nguyen; Thomas Bregnard; Joseph Weinstock; Michael Mattern; Irina Bezsonova; Wayne W Hancock; Suresh Kumar
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

7.  Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones.

Authors:  Giovanna Carrà; Cristina Panuzzo; Davide Torti; Guido Parvis; Sabrina Crivellaro; Ubaldo Familiari; Marco Volante; Deborah Morena; Marcello Francesco Lingua; Mara Brancaccio; Angelo Guerrasio; Pier Paolo Pandolfi; Giuseppe Saglio; Riccardo Taulli; Alessandro Morotti
Journal:  Oncotarget       Date:  2017-05-30

8.  IU1 suppresses proliferation of cervical cancer cells through MDM2 degradation.

Authors:  Liu Xu; Jing Wang; Xiaoning Yuan; Shuhua Yang; Xiaolong Xu; Kai Li; Yanqi He; Lei Wei; Jingwei Zhang; Yihao Tian
Journal:  Int J Biol Sci       Date:  2020-09-16       Impact factor: 6.580

9.  Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism.

Authors:  Nathan J Schauer; Xiaoxi Liu; Robert S Magin; Laura M Doherty; Wai Cheung Chan; Scott B Ficarro; Wanyi Hu; Rebekka M Roberts; Roxana E Iacob; Björn Stolte; Andrew O Giacomelli; Sumner Perera; Kyle McKay; Sarah A Boswell; Ellen L Weisberg; Arghya Ray; Dharminder Chauhan; Sirano Dhe-Paganon; Ken C Anderson; James D Griffin; Jianing Li; William C Hahn; Peter K Sorger; John R Engen; Kimberly Stegmaier; Jarrod A Marto; Sara J Buhrlage
Journal:  Sci Rep       Date:  2020-03-24       Impact factor: 4.379

10.  Inhibition of USP7 activity selectively eliminates senescent cells in part via restoration of p53 activity.

Authors:  Yonghan He; Wen Li; Dongwen Lv; Xin Zhang; Xuan Zhang; Yuma T Ortiz; Vivekananda Budamagunta; Judith Campisi; Guangrong Zheng; Daohong Zhou
Journal:  Aging Cell       Date:  2020-02-16       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.